Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Passage BIO, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −9 vs. Q4 2022
- Shares held
- 35.5M
- −1.83M (−4.9%) vs. Q4 2022
- Total value
- $34.0M
- −$17.5M (−34.0%) vs. Q4 2022
- New holders
- 5
- 15 more added
- Sold out
- 14
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 122 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 318 | $0 | 0.00% | +318 | New |
| Clearstead Advisors, LLC | 75 | $72 | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 89 | $85 | 0.00% | +89 | New |
| Group One Trading, L.P. | 100 | $96 | 0.00% | −200−66.7% | Reduced |
| US Bancorp | 500 | $479 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 534 | $511 | 0.00% | +304+132.2% | Added |
| Advisor Group Holdings, Inc. | 1,607 | $1.54K | 0.00% | +992+161.3% | Added |
| Federated Hermes, Inc. | 3,277 | $3.14K | 0.00% | −2,415−42.4% | Reduced |
| Federation des caisses Desjardins du Quebec | 8,000 | $7.66K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,129 | $9.70K | 0.00% | −3,956−28.1% | Reduced |
| Barclays PLC | 13,153 | $12.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 13,647 | $13.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 16,568 | $15.9K | 0.00% | +4,296+35.0% | Added |
| Dimensional Fund Advisors LP | 18,114 | $17.3K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,723 | $18.0K | 0.00% | +19,723 | New |
| Veritable, L.P. | 23,045 | $22.1K | 0.00% | +23,045 | New |
| Deutsche Bank AG | 24,697 | $23.7K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,526 | $26.4K | 0.00% | −1,166−4.1% | Reduced |
| Occudo Quantitative Strategies LP | 27,758 | $26.6K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 33,168 | $31.7K | 0.00% | +14,462+77.3% | Added |
| Tower Research Capital LLC (TRC) | 33,049 | $32.0K | 0.00% | −10,547−24.2% | Reduced |
| HighTower Advisors, LLC | 47,983 | $37.0K | 0.00% | +5,149+12.0% | Added |
| Annandale Capital, LLC | 54,338 | $52.0K | 0.02% | 00.0% | Unchanged |
| FMR LLC | 60,621 | $58.1K | 0.00% | +971+1.6% | Added |
| Northern Trust Corp | 60,902 | $58.3K | 0.00% | +1,879+3.2% | Added |
| Citadel Advisors LLC | 60,978 | $58.4K | 0.00% | −30,436−33.3% | Reduced |
| Vontobel Holding Ltd. | 80,000 | $76.6K | 0.00% | +45,000+128.6% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 82,895 | $79.4K | 0.00% | +576+0.7% | Added |
| Marquette Asset Management, LLC | 86,050 | $82.4K | 0.02% | +18,949+28.2% | Added |
| Cornercap Investment Counsel Inc | 101,488 | $97.2K | 0.02% | +1,236+1.2% | Added |
| RBF Capital, LLC | 110,807 | $106.1K | 0.01% | −3,400−3.0% | Reduced |
| Fiduciary Trust Co | 115,000 | $110.1K | 0.00% | +5,000+4.5% | Added |
| State Street Corp | 123,873 | $118.6K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 130,188 | $125.0K | 0.01% | +23,352+21.9% | Added |
| Morgan Stanley | 271,172 | $259.7K | 0.00% | +233,807+625.7% | Added |
| D. E. Shaw & Co., Inc. | 274,335 | $262.7K | 0.00% | −88,417−24.4% | Reduced |
| Two Sigma Investments, LP | 288,926 | $276.7K | 0.00% | −65,497−18.5% | Reduced |
| Millennium Management LLC | 298,090 | $285.0K | 0.00% | −191,411−39.1% | Reduced |
| Tang Capital Management LLC | 300,000 | $287.3K | 0.04% | +300,000 | New |
| Two Sigma Advisers, LP | 310,500 | $297.4K | 0.00% | −129,600−29.4% | Reduced |
| Geode Capital Management, LLC | 331,914 | $317.9K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 337,467 | $323.2K | 0.28% | 00.0% | Unchanged |
| Weiss Multi-Strategy Advisers LLC | 367,696 | $352.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 389,600 | $373.1K | 0.01% | −100,000−20.4% | Reduced |
| Acadian Asset Management LLC | 578,806 | $553.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 589,008 | $564.0K | 0.00% | 00.0% | Unchanged |
| Newtyn Management, LLC | 665,221 | $637.1K | 0.13% | −124,779−15.8% | Reduced |
| Renaissance Technologies LLC | 964,900 | $924.0K | 0.00% | −226,250−19.0% | Reduced |
| BlackRock Inc. | 1,053,999 | $1.01M | 0.00% | −69,698−6.2% | Reduced |
| Erste Asset Management GmbH | 1,560,800 | $1.50M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,017,883 | $1.93M | 0.00% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2.40M | 1.98% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 3,407,598 | $3.26M | 2.72% | +51,681+1.5% | Added |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $3.60M | 0.26% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 4,959,769 | $4.75M | 9.90% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 8,931,999 | $8.55M | 0.17% | 00.0% | Unchanged |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −822,105−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −240,000−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −182,978−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −156,900−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −49,114−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −37,806−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −22,661−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,728−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,761−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |